PUBLISHER: Global Insight Services | PRODUCT CODE: 2108055
PUBLISHER: Global Insight Services | PRODUCT CODE: 2108055
The global Single-use Assemblies Market is projected to grow from $6.9 billion in 2025 to $28.8 billion by 2035, at a compound annual growth rate (CAGR) of 15.3%. The single-use assemblies market is driven by the rapid expansion of biologics manufacturing and advanced bioprocessing technologies. According to the U.S. FDA, 46 novel drugs were approved in 2025, including 12 biologics (26% of all approvals), highlighting continued growth in biologic drug manufacturing, where single-use assemblies are widely used for sterile fluid transfer, filtration, and contamination control. Increasing adoption of disposable bioprocessing systems is further supporting market growth.
The Type segment of the Single-use Assemblies Market includes standard assemblies, customized assemblies, and others. Among these, customized assemblies hold a significant market share due to the increasing demand for flexible, application-specific solutions in biopharmaceutical manufacturing and advanced therapeutic production. Customized single-use assemblies help manufacturers optimize workflows, reduce contamination risks, and improve operational efficiency by integrating components according to specific process requirements. Standard assemblies are also widely adopted due to their cost-effectiveness, easy availability, and suitability for routine bioprocessing applications such as media preparation, fluid transfer, and filtration. The growing adoption of single-use technologies in biologics, vaccines, and cell and gene therapy manufacturing is driving demand for both standard and customized assembly solutions.
| Market Segmentation | |
|---|---|
| Type | Standard Assemblies, Customized Assemblies, Others |
| Product | Tubing, Connectors, Filters, Bags, Bioprocess Containers, Fittings, Clamps, Valves, Manifolds, Others |
| Services | Installation, Validation, Maintenance, Consulting, Training, Others |
| Technology | 3D Printing, Injection Molding, Blow Molding, Extrusion, Others |
| Component | Hose Barb, Luer Lock, Tri-Clamp, Quick Connect, Others |
| Application | Bioprocessing, Pharmaceutical Manufacturing, Vaccine Production, Cell Therapy, Gene Therapy, Others |
| Material Type | Polyethylene, Polypropylene, Silicone, Polyvinyl Chloride, Thermoplastic Elastomer, Others |
| Process | Upstream Processing, Downstream Processing, Fill-Finish Applications, Others |
| End User | Biopharmaceutical Companies, Contract Manufacturing Organizations, Research Institutes, Others |
| Functionality | Sterile, Non-Sterile, Others |
The Material Type segment of the Single-use Assemblies Market includes polyethylene, polypropylene, silicone, polyvinyl chloride, thermoplastic elastomer, and others. Among these, silicone and polypropylene are widely used due to their excellent biocompatibility, chemical resistance, flexibility, and suitability for critical bioprocessing applications. Polyethylene is gaining traction for fluid handling and storage applications due to its durability and low extractable characteristics. Thermoplastic elastomers are increasingly adopted as alternatives to traditional materials because of their flexibility and improved performance in single-use systems. The rising focus on contamination control, regulatory compliance, and efficient manufacturing processes is further supporting the adoption of advanced materials in single-use assemblies.
North America held the largest share of the global single-use assemblies market in 2025, driven by its advanced biopharmaceutical manufacturing industry, widespread adoption of single-use technologies, and strong investments in biologics, vaccines, and cell and gene therapy production. The region is home to leading biopharmaceutical companies, contract development and manufacturing organizations (CDMOs), and contract research organizations (CROs) that increasingly utilize pre-assembled, disposable fluid management systems to improve manufacturing flexibility, reduce contamination risks, and shorten production timelines. Growing demand for monoclonal antibodies, biosimilars, and personalized medicines, coupled with stringent regulatory standards for sterile manufacturing, has further strengthened market growth. Additionally, continuous innovation in bioprocessing technologies and automation reinforces North America's leadership in the global single-use assemblies market.
Asia Pacific is expected to witness the highest growth in the single-use assemblies market owing to rapid expansion of biopharmaceutical manufacturing, increasing biologics production, and rising investments in biotechnology infrastructure. Countries such as China, India, South Korea, Japan, and Singapore are expanding their biomanufacturing capabilities through government initiatives, private investments, and the establishment of new biologics production facilities. Growing adoption of single-use bioprocessing systems by CDMOs and biotechnology companies, combined with increasing demand for vaccines, biosimilars, and cell therapies, is accelerating market growth. Furthermore, lower manufacturing costs, favorable regulatory developments, and increasing technology transfer from global biopharmaceutical companies are expected to position Asia Pacific as the fastest-growing regional market throughout the forecast period.
Increasing Adoption of Customized and Automated Single-Use Bioprocessing Solutions:
The Single-use Assemblies Market is witnessing a strong trend toward the adoption of customized, pre-assembled, and automated single-use solutions in biopharmaceutical manufacturing. Pharmaceutical and biotechnology companies are increasingly replacing traditional stainless-steel systems with disposable assemblies such as tubing sets, bags, connectors, and filtration units to improve flexibility, reduce contamination risks, and accelerate production timelines. Advances in material science, modular designs, and integrated bioprocessing platforms are enabling manufacturers to develop application-specific solutions for biologics, vaccines, and cell and gene therapies. The growing focus on scalable and cost-efficient manufacturing processes is further driving the adoption of advanced single-use technologies.
Expansion of Biologics and Cell & Gene Therapy Manufacturing:
The increasing production of biologics, vaccines, and cell and gene therapies is a major driver of the Single-use Assemblies Market. The growing complexity of advanced therapies requires flexible and contamination-controlled manufacturing environments, increasing demand for disposable bioprocessing components. Single-use assemblies help manufacturers reduce cleaning requirements, minimize cross-contamination risks, and enable faster facility turnaround compared with conventional systems. Additionally, rising investments in biopharmaceutical manufacturing capacity, expansion of contract development and manufacturing organizations (CDMOs), and increasing adoption of continuous bioprocessing technologies are supporting market growth. The need for rapid production scalability and efficient manufacturing workflows continues to accelerate demand for single-use assembly solutions.
Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.